AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
Go back to AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026| AbbVie (NYSE: ABBV) | Delayed: 226.79 +10.30 (4.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.49 | 52 Week High | $68.12 | |||
| Open | $221.94 | 52 Week Low | $50.71 | |||
| Day High | $228.46 | P/E | 49.20 | |||
| Day Low | $221.94 | EPS | $4.61 | |||
| Volume | 1,665,187 | |||||

